Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Dynavax Technologies Corp (NASDAQ:DVAX)

20.50
Delayed Data
As of Sep 22
 -0.30 / -1.44%
Today’s Change
3.20
Today|||52-Week Range
21.85
+418.99%
Year-to-Date

Today’s Trading

Previous close20.80
Today’s open20.80
Day’s range20.25 - 21.00
Volume918,876
Average volume (3 months)2,563,721
Market cap$1.2B
Dividend yield--
Data as of 4:00pm ET, 09/22/2017

Growth & Valuation

Earnings growth (last year)+10.15%
Earnings growth (this year)+31.42%
Earnings growth (next 5 years)--
Revenue growth (last year)+172.67%
P/E ratioNM
Price/Sales13.77
Price/Book8.87

Competitors

 Today’s
change
Today’s
% change
AIMTAimmune Therapeutics...-0.28-1.17%
CLLSCellectis SA-0.14-0.50%
XNCRXencor Inc-0.29-1.31%
DERMDermira Inc-0.32-1.20%
Data as of 4:00pm ET, 09/22/2017

Financials

Next reporting dateNovember 6, 2017
EPS forecast (this quarter)-$0.45
Annual revenue (last year)$11.0M
Annual profit (last year)-$112.4M
Net profit margin-1,018.24%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Eddie J. Gray
Senior Vice President-Operations &
Quality
David F. Novack
Corporate headquarters
Berkeley, California

Forecasts